Bellevue Life Sciences Acquisition Corp.
BLAC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,491 | $13,491 | $13,491 | $51,677 |
| - Cash | $2,177 | $1,584 | $1,596 | $66 |
| + Debt | $50 | $63 | $567 | $1,763 |
| Enterprise Value | $11,364 | $11,969 | $12,462 | $53,374 |
| Revenue | $628 | $1,136 | $761 | $0 |
| % Growth | -44.7% | 49.2% | – | – |
| Gross Profit | $262 | $33 | $169 | $0 |
| % Margin | 41.7% | 2.9% | 22.2% | – |
| EBITDA | $0 | -$5,229 | -$2,918 | -$2,144 |
| % Margin | 0% | -460.5% | -383.3% | – |
| Net Income | -$3,195 | -$5,225 | -$11,393 | -$2,022 |
| % Margin | -508.9% | -460.2% | -1,496.6% | – |
| EPS Diluted | -0.71 | -1.17 | -2.54 | -0.45 |
| % Growth | 39.3% | 53.9% | -464.4% | – |
| Operating Cash Flow | -$3,150 | -$44 | -$64 | -$503 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,150 | -$44 | -$64 | -$503 |